These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18057297)

  • 1. Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab.
    Murthy R; Eng C; Krishnan S; Madoff DC; Habbu A; Canet S; Hicks ME
    J Vasc Interv Radiol; 2007 Dec; 18(12):1588-91. PubMed ID: 18057297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
    Lewandowski RJ; Thurston KG; Goin JE; Wong CY; Gates VL; Van Buskirk M; Geschwind JF; Salem R
    J Vasc Interv Radiol; 2005 Dec; 16(12):1641-51. PubMed ID: 16371530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
    Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
    J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
    Malik Z; Eng C
    Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584
    [No Abstract]   [Full Text] [Related]  

  • 5. [90Y]yttrium microspheres radioembolotherapy in desmoplastic small round cell tumor hepatic metastases.
    Subbiah V; Murthy R; Anderson PM
    J Clin Oncol; 2011 Apr; 29(11):e292-4. PubMed ID: 21245431
    [No Abstract]   [Full Text] [Related]  

  • 6. State of the art: radiolabeled microspheres treatment for liver malignancies.
    Deleporte A; Flamen P; Hendlisz A
    Expert Opin Pharmacother; 2010 Mar; 11(4):579-86. PubMed ID: 20163269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare costs associated with bevacizumab and cetuximab in second-line treatment of metastatic colorectal cancer.
    Yang H; Yu AP; Wu EQ; Yim YM; Yu E
    J Med Econ; 2011; 14(5):542-52. PubMed ID: 21728912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in everyday surgical practice: synchronous bilobar hepatic colorectal metastases--newer multimodality approach.
    Lygidakis NJ; Bhagat AD; Vrachnos P; Grigorakos L
    Hepatogastroenterology; 2007 Jun; 54(76):1020-4. PubMed ID: 17629030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two radically resected colorectal carcinoma cases with unresectable liver metastasis after adjuvant chemotherapy with bevacizumab].
    Sugiyama M; Kakeji Y; Kubo N; Nakanoko T; Fujinaka Y; Ando K; Masuda T; Yagi K; Yoshinaga K; Saeki H; Endo K; Emi Y; Morita M; Maehara Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2169-71. PubMed ID: 20037359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perforating dermatosis in a patient receiving bevacizumab.
    Vano-Galvan S; Moreno C; Medina J; Pérez-García B; García-López JL; Jaén P
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):972-4. PubMed ID: 19470057
    [No Abstract]   [Full Text] [Related]  

  • 11. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results.
    Murthy R; Xiong H; Nunez R; Cohen AC; Barron B; Szklaruk J; Madoff DC; Gupta S; Wallace MJ; Ahrar K; Hicks ME
    J Vasc Interv Radiol; 2005 Jul; 16(7):937-45. PubMed ID: 16002501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.
    Yoo PS; Lopez-Soler RI; Longo WE; Cha CH
    Clin Colorectal Cancer; 2006 Sep; 6(3):202-7. PubMed ID: 17026789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two cases of colorectal cancer patients with poor performance status who had unresectable liver metastasis effectively treated by cetuximab].
    Osawa G; Yoshimatsu K; Yokomizo H; Matsumoto A; Yano Y; Itagaki H; Otani T; Fujimoto T; Umehara A; Ogawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(11):2189-91. PubMed ID: 21084825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
    Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
    Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres.
    Evans KA; Richardson MG; Pavlakis N; Morris DL; Liauw W; Bester L
    J Vasc Interv Radiol; 2010 Oct; 21(10):1521-6. PubMed ID: 20813542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study.
    Tamandl D; Gruenberger B; Klinger M; Herberger B; Kaczirek K; Fleischmann E; Gruenberger T
    Ann Surg; 2010 Jul; 252(1):124-30. PubMed ID: 20562613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case series of cetuximab monotherapy for patients with pre-treated colorectal cancer complicated with hyperbilirubinemia due to severe liver metastasis.
    Shitara K; Takahari D; Yokota T; Shibata T; Ura T; Muro K; Inaba Y; Yamaura H; Sato Y; Najima M; Utsunomiya S
    Jpn J Clin Oncol; 2010 Mar; 40(3):275-7. PubMed ID: 19946122
    [No Abstract]   [Full Text] [Related]  

  • 18. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.
    Kennedy AS; Coldwell D; Nutting C; Murthy R; Wertman DE; Loehr SP; Overton C; Meranze S; Niedzwiecki J; Sailer S
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):412-25. PubMed ID: 16690429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential FDG PET/CT in 90Y microsphere treatment of unresectable colorectal liver metastases.
    Bienert M; McCook B; Carr BI; Geller DA; Sheetz M; Amesur N; Avril N
    Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):723. PubMed ID: 15599525
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients.
    Stubbs RS; O'Brien I; Correia MM
    ANZ J Surg; 2006 Aug; 76(8):696-703. PubMed ID: 16916386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.